MedPath

Glycemic Index testing of high protein supplement

Not yet recruiting
Conditions
BMI greater than 18.5 and less than 22.9
Registration Number
CTRI/2022/03/041107
Lead Sponsor
Madras Diabetes Research Foundation
Brief Summary

Research studies have shown that lifestyle; in particular dietary aspects play an important role in preventing / increasing the burden of the chronic diseases. Dietary habits could therefore be modified to exert a positive impact in the prevention and treatment. It has been suggested that the high glycemic carbohydrate foods -those foods containing carbohydrates which elicit rapid blood glucose rise and thereby increase the insulin demand leading to hyperinsulinemia, insulin resistance and type 2 diabetes. Hence, there is a need to understand the blood glucose raising potential of foods in India to be of an important tool to aid in the prevention and or management of diabetes and its complication. Thus, evolved the concept of ‘Glycemic Index’ (GI) which ranks the foods, based on the speed at which the food raises the blood glucose in a scale of 0 to 100, 100 indicating high glycemic index corresponds to oral glucose’s GI. Today, India leading the world with the largest number of diabetic volunteers causing a heavy economic burden to the country urgently needs to look at cost effective strategies to combat this situation. A cost-effective dietary approach like estimating and understanding the role of glycemic index of various Indian foods in the lifestyle related diseases like diabetes is urgently needed.

**Aim:** To measure glycemic index (GI) of high protein nutrition supplement with immuno nutrients for people with muscle and weight loss

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Age -18 to 45 years BMI ≥18.5 to ≤ 22.9 kg/ m2 (as per WHO cut off for normal BMI) Both male and female Willingness to consume the test foods no known food allergy or intolerance; no medications known to affect glucose tolerance (excluding oral contraceptives) — stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are.

Exclusion Criteria

a known history of diabetes mellitus or the use of antihyperglycemic drugs or insulin to treat diabetes and related conditions pregnant or lactating women a major medical or surgical event requiring hospitalization within the preceding 3 months; the presence of disease or drug(s) which influence digestion and absorption of nutrients; the use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat (distribution).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glycemic index (GI) category of food productsCapillary blood glucose will be assessed at -5, 0 (fasting), 15, 30, 45,60,90,120 mins post ingestion of test and reference foods. The testing will be done on separate days for test and reference foods.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Madras Diabetes Research Foundation

🇮🇳

Chennai, TAMIL NADU, India

Madras Diabetes Research Foundation
🇮🇳Chennai, TAMIL NADU, India
SUDHA VASUDEVAN
Principal investigator
9840014480
drmohans@diabetes.ind.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.